Expanded reimbursement for planned treatment abroad could attract more international patients to India, according to a senior Apollo Hospitals executive
India’s medical tourism industry could experience substantial growth if international health insurers expand coverage for patients seeking planned treatment abroad. Sangita Reddy, Joint Managing Director of Apollo Hospitals, has identified insurance reimbursement as a potentially important factor in attracting more patients from Western countries to India’s private healthcare sector.
Speaking to the Press Trust of India on the sidelines of the Garmin Health Summit in Bangkok, Reddy argued that broader international insurance coverage could make India’s medical services accessible to a larger patient population. The country already attracts international patients, including non-resident Indians, but insurance restrictions and the need for direct payment can limit access to overseas treatment.
The comments come as industry estimates point to continued expansion of India’s medical tourism market. According to figures cited in Indian media reports, the sector was valued at approximately USD 8.7 billion in 2025 and could reach USD 16.2 billion by 2030. These projections indicate considerable growth potential, although they do not establish how much additional demand might result specifically from changes in insurance coverage.
Insurance reimbursement could reshape patient flows
India has developed a substantial international healthcare offering, with private hospital groups providing services in cardiovascular medicine, oncology, orthopaedics, organ transplantation and other specialised fields.
Competitive treatment costs have been an important factor in attracting patients from overseas. However, the financial advantages of receiving care in India depend on individual circumstances, including the procedure, insurance arrangements, travel expenses and postoperative requirements.
Reddy suggested that international insurers could play a greater role in enabling patients to access Indian healthcare providers. Broader coverage for planned overseas treatment could potentially benefit both patients seeking more affordable care and insurers looking to manage medical expenditure.
Such arrangements would require more than simply extending existing travel insurance policies. Emergency medical coverage during an overseas holiday is fundamentally different from insurance reimbursement for a treatment deliberately scheduled in another country.
Insurers would need to establish eligibility criteria, contractual relationships with healthcare providers, payment procedures and arrangements for managing complications. Questions surrounding clinical quality, patient safety and continuity of care would also be central to any expansion.
For hospitals, direct agreements with international insurers could reduce some of the administrative and financial uncertainty faced by patients who currently pay for treatment themselves.
Nevertheless, the reported comments do not identify any new insurance agreements or confirm that major global insurers are preparing to introduce broader coverage for medical tourism in India.
Growing market faces structural challenges
India’s private healthcare sector has invested in specialist hospitals, advanced medical technology and international patient services, particularly in major centres such as Delhi, Mumbai, Chennai, Hyderabad and Bengaluru.
These facilities serve patients from a variety of international markets, although treatment preferences, insurance arrangements and referral pathways differ considerably between countries.
The potential expansion of insurance-funded medical travel could create opportunities to reach patients who might otherwise consider overseas treatment financially or administratively impractical.
However, insurers considering cross-border reimbursement would need reliable information about treatment quality, hospital accreditation, medical outcomes and the total costs of care. Postoperative follow-up and responsibility for complications would be particularly important for patients returning to their home countries.
The market projections cited in the report suggest that India's medical tourism industry could nearly double in value between 2025 and 2030. The estimates should nevertheless be treated as forecasts rather than confirmed future revenues.
India’s international healthcare competitiveness will also depend on factors beyond price, including visa procedures, air connectivity, patient communication and the ability of hospitals to coordinate complex treatment journeys.
For the wider medical tourism industry, the discussion highlights the growing importance of financing arrangements in international patient mobility. While lower treatment prices can encourage patients to consider healthcare abroad, insurance reimbursement could influence whether such treatment becomes a practical option for larger groups of patients.
Whether global insurers will substantially expand coverage for planned medical travel to India remains uncertain. For now, the proposal illustrates how closer cooperation between hospitals and insurance companies could become an important element in the next phase of international healthcare development.
Image Credit: AI generated illustration
